Australian Diver Accreditation Scheme
Australian Diver Accreditation Scheme (ADAS) is an Australian based international accreditation scheme for occupational divers and diving supervisors. The scheme is recognized for its high standards in safety, training, and diving technology.
History[edit]
The Australian Diver Accreditation Scheme was established in 1995 by the Australian Government in response to the need for a unified standard of training and accreditation for occupational divers. The scheme was developed in consultation with the diving industry, trade unions, and government regulatory bodies.
Accreditation[edit]
ADAS accredits divers at four levels, each with its own specific training and competency requirements. The levels are:
- ADAS Part 1 - SSBA to 30m
- ADAS Part 2 - SSBA to 50m
- ADAS Part 3 - SSBA to 50m (including wet bell)
- ADAS Part 4 - Closed Bell (Saturation Diving)
Training[edit]
Training under the Australian Diver Accreditation Scheme is comprehensive and rigorous. It covers a wide range of skills and knowledge areas, including diving physics and physiology, diving medicine, decompression procedures, diving systems and equipment, emergency procedures, and underwater work skills.
Recognition[edit]
The Australian Diver Accreditation Scheme is recognized internationally and is a member of the International Diving Regulators and Certifiers Forum (IDRCF). ADAS accredited divers are able to work in a wide range of diving roles worldwide.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian